Most liver tumors are benign and hypervascular, and it is important to avoid unnecessary interventions for benign lesions. This review describes the typical and atypical imaging features of common hypervascular benign liver tumors and outlines a general approach to distinguishing between benign and malignant hepatic lesions. There are many types of benign liver tumors that need to be differentiated from hepatocellular carcinoma (HCC). Therefore, it is very important to know the imaging characteristics of benign tumors. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging is helpful in diagnosing hypervascular pseudotumors, focal nodular hyperplasia, and nodular lesions associated with alcohol-induced hepatitis. There are also some hypervascular malignant tumors, such as cholangiocarcinoma, cholangiolocellular carcinoma, mixed type tumors, and metastatic liver tumors, which also required differentiation from HCC.
Introduction
Although liver parenchyma is fed by both the hepatic artery and portal vein, classical hepatocellular carcinoma (HCC) is usually fed by the hepatic artery only. Therefore, imag-nosing liver tumors. Dynamic computed tomography (CT) and magnetic resonance imaging (MRI), CT during arterial portography (CTAP), and CT hepatic arteriography (CTHA) have -nant liver tumors, the latter consisting mainly of HCC.
Key Points of Imaging Diagnosis of Benign Hypervascular Liver Tumors
There are many types of benign hypervascular tumors that need to be differentiated from hypervascular HCC. When a lesion is diagnosed as benign, it is usually enough to fol-cal intervention. The most common benign hypervascular liver tumor requiring differential alcohol-induced liver disease or Budd-Chiari syndrome, hepatocellular adenoma (HCA), anepithelial and mesenchymal tumors.
Hemangioma
Hemangioma of the liver is the most common benign liver tumor and is usually of the - commonly used on dynamic MRI because Gd-EOB-DTPA-enhanced MRI has been reported the enhancement pattern of hemangioma on Gd-EOB-DTPA-enhanced MRI is different from Washout of Gd-EOB-DTPA from the blood pool is much faster than that of iodine contrast -). On hancement patterns in arterial phase images (spotty, globular, or bright dot enhancement)
Hypervascular Pseudolesions
Hypervascular pseudolesions are hypervascular enhanced regions in the liver parenchyma on arterial phase images caused by AP-shunts. There is no tumor in the hypervascular region. As is often the case in chronic liver diseases such as hypervascular HCC, the differential diagnosis is important. AP-shunts are often seen in the subcapsular area of the liver and some AP shunts have a round shape, and this complicates the differential diagnosis. Imaging in hepatocyte-phase images on Gd-EOB-DTPA-enhanced MRI, indicating no decrease of Gd- 
Nodular Lesions Associated with Alcohol-Induced Chronic Hepatic Disease (FNH-Like Nodules)
syndrome.
pervascular tumors such as metastasis, hepatocellular adenoma, or HCC may mimic FNHcorona enhancement on CT hepatic angiography. Moreover, they take up SPIO and Gd-EOB--PA-enhanced MRI, in contrast to malignant liver tumors and hepatocellular adenoma, the ). In cases seen Hepatocellular Adenoma HCA is a benign tumor that requires differentiation from HCC and FNH. The etiology of enomas, mainly in the periphery , those are seen as areas of hypointensity in the hepatocyte
Angiomyolipoma
The fat component can be detected by CT and ultrasonography. When the fat deposition is very minor, chemical-shift MR imaging is useful because of its sensitivity. Other benign liver sometimes needs to be differentiated from hypervascular HCC. Venous drainage of AML is -ment and mimic hemangioma.
from HCC.
-sions such as atypical HCC, intrahepatic cholangiocarcinoma, metastatic tumors, or abscess enables the correct diagnosis to be made, but sometimes a biopsy is required.
Key Points of Imaging Diagnosis of Malignant Hypervascular Liver Tumors Other Than HCC
The malignant hypervascular liver tumors that require differentiation from HCC include cholangiocarcinoma, cholangiolocellular carcinoma, mixed tumor containing HCC and cholan- according to the compositional balance of HCC and cholangiocarcinoma. Consequently, it is 
